Zepbound Cost 2026: Monthly Pricing Breakdown
Zepbound cost breakdown for 2026: monthly pricing without insurance, dose-by-dose expenses, Eli Lilly savings programs, and where compounded tirzepatide fits as a separate regulatory pathway.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Pricing data reflects current market information and is updated when significant changes occur.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Zepbound Pricing in 2026
Zepbound, Eli Lilly's tirzepatide product approved specifically for chronic weight management, entered the market in late 2023 as the first tirzepatide product with an FDA weight loss indication. For patients and their doctors, this dedicated approval was significant because it created a clearer pathway for insurance coverage for weight loss treatment. However, the retail pricing tells a familiar story, brand-name GLP-1 medications in the US remain prohibitively expensive for most patients without insurance.
Zepbound's list price in 2026 sits at approximately $1,060 per month without insurance. This price is the same regardless of dose level, from the 2.5mg starting dose through the 15mg maximum dose. Eli Lilly has positioned Zepbound slightly below competitor pricing for Wegovy, though the difference is relatively small in the context of monthly costs exceeding $1,000.
For patients paying out of pocket, the annual cost of Zepbound approaches $12,720. That reality is why many patients ask a provider about compounded tirzepatide, which follows a different regulatory pathway and is not FDA-approved as a drug.
Zepbound Cost by Dose Level
| Dose Level | Zepbound Retail (Monthly) | Zepbound Retail (Annual) | Titration Stage |
|---|---|---|---|
| 2.5mg weekly | ~$1,060/mo | ~$12,720/yr | Starting dose (first 4 weeks) |
| 5mg weekly | ~$1,060/mo | ~$12,720/yr | First maintenance dose |
| 7.5mg weekly | ~$1,060/mo | ~$12,720/yr | Titration step |
| 10mg weekly | ~$1,060/mo | ~$12,720/yr | Maintenance dose |
| 12.5mg weekly | ~$1,060/mo | ~$12,720/yr | Titration step |
| 15mg weekly | ~$1,060/mo | ~$12,720/yr | Maximum labeled dose |
Zepbound is priced identically at every dose level, so a patient in the 2.5mg titration month pays the same as a patient at the 15mg maximum dose. If you want to see how Trimi's own flat monthly rate is structured and what it includes, our cost guide breaks it down by plan length.
Pricing Note
Telehealth and pharmacy pricing changes frequently. The figures in this comparison reflect observed pricing in early 2026. Always verify current pricing directly on each provider's website before making a decision.
Insurance Coverage for Zepbound
Zepbound's dedicated FDA approval for weight management gives it a theoretical advantage over Mounjaro for insurance coverage of obesity treatment. However, the practical reality of insurance coverage in 2026 remains inconsistent. While more plans are beginning to cover anti-obesity medications, coverage is far from universal.
Patients who do have insurance coverage for Zepbound should be aware of several potential cost factors beyond the base medication price: prior authorization requirements that can delay treatment by weeks, step therapy mandates requiring trial of other medications first, specialty tier copays that may range from $100 to $500 per month even with coverage, and annual out-of-pocket maximums that reset each year.
For patients whose insurance does not cover Zepbound, or whose coverage leaves them with high out-of-pocket costs, compounded tirzepatide through a provider like Trimi eliminates the insurance complexity entirely. No prior authorization, no formulary battles, no coverage denials, just straightforward monthly pricing that includes everything you need.
Zepbound Savings Programs
Eli Lilly has introduced several savings programs to help patients access Zepbound at lower costs. Understanding what these programs offer, and their limitations, is important for patients evaluating their options.
Savings program limitations:
Most programs require existing commercial insurance coverage as a prerequisite
Medicare, Medicaid, and government insurance participants are typically ineligible
Programs have maximum benefit caps that limit total savings
Eligibility criteria may exclude patients based on plan type or formulary status
Programs have expiration dates and may not be renewed
Enrollment processes can be complex and time-consuming
For patients who qualify for Eli Lilly's savings programs and have supporting insurance coverage, these programs can meaningfully reduce what they pay for Zepbound at the counter. For everyone else, which represents the majority of patients seeking weight loss treatment, it is worth asking a licensed provider which treatment paths are actually open to you. Compare the options in detail with our Zepbound alternatives guide.
Long-Term Cost Projections
GLP-1 weight loss treatment is most effective when sustained over time. Patients who stop treatment often experience weight regain, making long-term affordability a critical factor in treatment planning. What you pay for Zepbound across a multi-year course depends almost entirely on which access path you qualify for and whether you keep qualifying.
| Treatment Duration | Zepbound at Full Retail | With a $100/mo Specialty Copay | With a $25/mo Savings Card |
|---|---|---|---|
| 6 months | ~$6,360 | ~$600 | ~$150 |
| 1 year | ~$12,720 | ~$1,200 | ~$300 |
| 2 years | ~$25,440 | ~$2,400 | ~$600 |
| 3 years | ~$38,160 | ~$3,600 | ~$900 |
These projections assume the access path holds steady, which is usually the optimistic case. Savings-card programs carry annual benefit caps and expiration dates, formularies reset each plan year, and specialty-tier copays can change at renewal. A patient who starts at $25 per month should plan for the possibility of moving to a higher tier before three years are up.
Bottom Line
Zepbound is an outstanding medication backed by exceptional clinical data. Its dedicated FDA approval for weight management is a meaningful distinction that may improve insurance coverage prospects for some patients. However, at approximately $1,060 per month without insurance, Zepbound remains unaffordable for the majority of patients seeking weight loss treatment.
Compounded tirzepatide is a separate regulatory route. Through Trimi, patients access compounded tirzepatide at a flat $125 per month with transparent pricing, dedicated weight management support, and no long-term contracts. It is prepared per individual prescription and is not FDA-approved as a drug, so it is a decision to make with your provider.
Frequently Asked Questions
How much does Zepbound cost per month in 2026?
Zepbound's retail price without insurance is approximately $1,060 per month in 2026, consistent across all dose levels. Over a full year, that totals approximately $12,720. With insurance coverage (where available), copays vary widely from $25 to $500 per month depending on your plan. Prior authorization, step therapy, and specialty-tier placement all change what you actually owe, so confirm your own copay with your pharmacy benefit manager before you fill.
Is Zepbound cheaper than Mounjaro?
Zepbound and Mounjaro contain the identical active ingredient (tirzepatide) made by Eli Lilly. Zepbound's list price is approximately $1,060 per month, while Mounjaro is approximately $1,050 per month, essentially the same. The primary difference between the two brands is the FDA-approved indication: Zepbound is approved for weight management while Mounjaro is approved for type 2 diabetes. Insurance coverage may differ between the two based on the approved indication and your specific plan.
Does the Zepbound savings card work?
Eli Lilly offers a savings program for Zepbound that can reduce out-of-pocket costs for eligible patients. The program typically requires commercial insurance coverage and has restrictions on who can participate. Patients on Medicare, Medicaid, or without insurance generally cannot use the savings card. When eligible, patients may pay as little as $25 per month. However, eligibility criteria, benefit caps, and program duration limit the long-term reliability of this savings pathway.
Does Medicare cover Zepbound?
Medicare coverage for Zepbound is evolving. Traditional Medicare Part D plans have historically excluded anti-obesity medications, but policy changes have been expanding coverage. As of 2026, some Medicare plans may cover Zepbound with prior authorization, but coverage is not universal. Patients on Medicare should verify their specific plan's formulary and discuss options with their provider. Medicare beneficiaries generally cannot use manufacturer savings cards, so formulary placement and tier are the main factors in what you pay.
Why is Zepbound so expensive?
Zepbound's price reflects Eli Lilly's enormous investment in developing tirzepatide, including years of clinical trials (the SURMOUNT program), FDA regulatory approval, manufacturing infrastructure, and global marketing. These costs are built into the retail price and protected by patent exclusivity. The US pharmaceutical market allows manufacturers to set prices without government price controls, resulting in prices that are several times higher than in other developed countries. Compounded preparations follow an entirely different regulatory pathway: they are made per individual prescription by a licensed pharmacy and are not FDA-approved, reviewed, or marketed as branded products.
How does compounded tirzepatide from a telehealth provider work?
Compounded tirzepatide is prepared by a licensed compounding pharmacy against an individual prescription written after a provider evaluation. It is not FDA-approved as a drug, and the FDA does not review compounded preparations for safety or effectiveness. Platforms like Trimi offer compounded tirzepatide at $125 per month, a flat rate that includes the medication, provider consultations, medical oversight, and shipping with no hidden fees or long-term contracts.
Can I get Zepbound from Canada or overseas for less?
While some patients explore international pharmacies for lower drug prices, importing prescription medications for personal use exists in a legal gray area. The FDA generally does not approve of importing prescription drugs from other countries, and there are quality and safety concerns with overseas pharmacies. Compounded tirzepatide from US-based, state-licensed compounding pharmacies stays inside the US pharmacy regulatory system, without the legal and quality complications of international medication sourcing, though it is not FDA-approved as a drug.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Pricing information reflects publicly available data and may change. Always verify current pricing directly with providers. Trimi offers compounded tirzepatide, readers should be aware of our perspective when evaluating the information presented.